Company

Axogen, Inc. (AXGN)

Standardized SEC financial data for Axogen, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000805928 · NASDAQ · Electromedical & Electrotherapeutic Apparatus.

Gross margin

74.3%

Operating margin

-3.5%

Net margin

-7.0%

Revenue growth (YoY)

20.2%

Return on equity

-12.2%

ROIC

-4.4%

Free cash flow

-$2.9M

Debt / equity

0.38×

Ratios for fiscal year 2025, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$112.3M	$127.4M	$138.6M	$159.0M	$187.3M	$225.2M
Cost of revenue	$21.6M	$22.9M	$29.8M	$37.1M	$45.4M	$57.9M
Gross profit	$90.7M	$104.4M	$108.8M	$121.9M

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$55.6M	$39.0M	$21.5M	$37.0M	$33.6M	$39.5M
Inventory	$12.5M	$16.7M	$18.9M	$23.0M	$33.2M	$42.4M
Total current assets	$145.3M	$127.0M	$98.1M	$88.0M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$9.6M	-$13.4M	-$16.1M	-$5.7M	$4.5M	$812K
Capital expenditures	$21.9M	$27.8M	$20.1M	$13.9M	$3.1M	$3.7M
Free cash flow	-$31.5M	-$41.2M	-$36.1M	-$19.6M

Get AXGN data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/AXGN/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/AXGN/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View AXGN filings on SEC EDGAR →